Gemphire Therapeutics - 48 Year Dividend History | GEMP

Historical dividend payout and yield for Gemphire Therapeutics (GEMP) since 1971. The current TTM dividend payout for Gemphire Therapeutics (GEMP) as of April 25, 2019 is $0.00. The current dividend yield for Gemphire Therapeutics as of April 25, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.017B $0.000B
Gemphire Therapeutics Inc. is a biopharmaceutical company. It focused on developing and commercializing therapies for the treatment of dyslipidemia. The company's product candidate is gemcabene (CI-1027), an oral therapy for patients who are unable to achieve normal levels of LDL-C or triglycerides with currently approved therapies. Gemphire Therapeutics Inc. is headquartered in Northville, Michigan.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $109.824B 12.37
Gilead Sciences (GILD) United States $80.063B 10.19
Bio-Techne Corp (TECH) United States $7.211B 48.58